Gerresheimer Lohr GmbH
Location
Bayern
Founded
1901-01-01
Website
Risk Signals
1201 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Glass Containers, Laboratory Apparatus and Furniture, Professional Equipment and Supplies, Not Elsewhere Classified, Durable Goods, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Gerresheimer Lohr GmbH
Live alerts from global media, monitored by Business Radar
2025-02-10 (wallstreet-online.de)
Hauck Aufhäuser Investment Banking classifies Gerresheimer AG on 'Buy' - 10.02.2025
10.02.2025 - Hauck Aufhäuser Investment Banking left the classification for Gerresheimers on 'Buy' with a price target of 105 euros. The purchase interest known before the weekend of investment companies at the manufacturer of ...
Read more
2024-12-02 (boerse-social.com)
Gerresheimer is building new production capacities for glass syringes at the Skopje site (photo).
Gerresheimer is building new production capacities for glass syringes at the Skopje location PHOTO Düsseldorf / OTS - Expansion of the location in the Republic of North Macedonia to include a production hall. Total investment volume of over 100 million euros
Read more
2024-12-02 (nebenwerte-magazin.com)
Gerresheimer's new factory hall in Skopje strengthens global capacities for glass spraying
Gerresheimer AG: New factory hall in Skopje strengthens global capacities for glass injection molding
Read more
2024-12-02 (4investors.de)
Gerresheimer expands its Skopje location
Gerresheimer is investing over 100 million euros in new production capacities for glass syringes in Skopje. Production start at the end of 2024.
Read more
2024-12-02 (marketwatch.com)
gerresheimer invests 106 million in new syringe production hall
B Maitan Sardan
Read more
2024-11-29 (investmentweek.com)
UBS sees potential at Gerresheimer thanks to Novo Nordisk Trends
The analysis department of the renowned major Swiss bank UBS recently confirmed its buy recommendation for Gerresheimer and continued to set the price target at an attractive 132 euros. The reason for the optimism is promising study data on the innovative weight reducer CagriSema from the Danish pharmaceutical giant Novo Nordisk. These could prove to be a significant growth driver for the packaging and syringe specialist
Read more
2024-10-11 (wallstreet-online.de)
Gerresheimer and many more: At the 12th IIF, top managers will answer questions
On October 15th, the International Investment Forum (IIF) will host its 12th live online event. Managers from 20 companies present online. On the 15th...
Read more
2024-10-03 (investing.com)
Reduced outlook for Gerresheimer stock due to delays in market recovery and production shutdown By Investing.com
Reduced outlook for Gerresheimer stock due to delays in market recovery and production shutdown
Read more
2024-10-02 (traderfox.com)
ANALYSIS FLASH: Hauck Aufhäuser IB lowers target for Gerresheimer - 'Buy'
HAMBURG (dpa-AFX Broker) - Hauck Aufhäuser Investment Banking has lowered the price target for Gerresheimer from 122 to 105 euros, but the rating...
Read more